LEP and obesity due to melanocortin 4 receptor deficiency: Considering that chronic leptin treatment mimics the hyperleptinemic state without the influence of other obesity-associated factors [17, 28–33] and that leptin also acts indirectly on the renal tissue, we hypothesized that leptin infusion could induce RAS activation and consequently, changes in blood pressure, renal function and morphology.